JYSB2400174 | 甘精胰岛素利司那肽注射液(Ⅱ) | insulin glargine;lixisenatide | Injection | Biological Products | Supplementary Application | 2024-08-09 | | | | | view |
JYSB2400173 | 甘精胰岛素利司那肽注射液(Ⅰ) | insulin glargine;lixisenatide | Injection | Biological Products | Supplementary Application | 2024-08-09 | | | | | view |
JYSB2400100 | 甘精胰岛素利司那肽注射液(Ⅱ) | insulin glargine;lixisenatide | Injection | Biological Products | Supplementary Application | 2024-05-06 | | | | | view |
JYSB2400099 | 甘精胰岛素利司那肽注射液(Ⅰ) | insulin glargine;lixisenatide | Injection | Biological Products | Supplementary Application | 2024-05-06 | | | | | view |
JYSB2300196 | 甘精胰岛素利司那肽注射液(Ⅱ) | insulin glargine;lixisenatide | Injection | Biological Products(3.1) | Supplementary Application | 2023-11-11 | | | | | view |
JYHZ2100679 | 利司那肽注射液 | lixisenatide | Injection | Chemical Drugs | License Renew | 2021-10-27 | | | | | view |
JYHZ2100678 | 利司那肽注射液 | lixisenatide | Injection | Chemical Drugs | License Renew | 2021-10-27 | | | | | view |
JYHZ2100677 | 利司那肽注射液 | lixisenatide | Injection | Chemical Drugs | License Renew | 2021-10-27 | | | | | view |
JYHZ2100676 | 利司那肽注射液 | lixisenatide | Injection | Chemical Drugs | License Renew | 2021-10-27 | | | | | view |
JYHZ2100675 | 利司那肽注射液 | lixisenatide | Injection | Chemical Drugs | License Renew | 2021-10-27 | | | | | view |
JYHF1800008 | 利司那肽注射液 | lixisenatide | Injection | Chemical Drugs | Supplementary Application | 2018-01-26 | 赛诺菲(中国)投资有限公司 | Sanofi (China) Investment Co Ltd | Certificate Issued | 2018-03-02 | view |
JYHF1800007 | 利司那肽注射液 | lixisenatide | Injection | Chemical Drugs | Supplementary Application | 2018-01-26 | 赛诺菲(中国)投资有限公司 | Sanofi (China) Investment Co Ltd | Certificate Issued | 2018-03-02 | view |
JYHB2300472 | 利司那肽注射液 | lixisenatide | Injection | Chemical Drugs | Supplementary Application | 2023-08-25 | | | | | view |
JYHB2300471 | 利司那肽注射液 | lixisenatide | Injection | Chemical Drugs | Supplementary Application | 2023-08-25 | | | | | view |
JYHB2300470 | 利司那肽注射液 | lixisenatide | Injection | Chemical Drugs | Supplementary Application | 2023-08-25 | | | | | view |
JYHB2300469 | 利司那肽注射液 | lixisenatide | Injection | Chemical Drugs | Supplementary Application | 2023-08-25 | | | | | view |
JYHB2300468 | 利司那肽注射液 | lixisenatide | Injection | Chemical Drugs | Supplementary Application | 2023-08-25 | | | | | view |
JYHB2300467 | 利司那肽注射液 | lixisenatide | Injection | Chemical Drugs | Supplementary Application | 2023-08-25 | | | | | view |
JYHB2001340 | 利司那肽注射液 | lixisenatide | Injection | Chemical Drugs | Supplementary Application | 2020-08-21 | 赛诺菲(中国)投资有限公司 | Sanofi (China) Investment Co Ltd | Filed | 2020-09-09 | view |
JYHB2001339 | 利司那肽注射液 | lixisenatide | Injection | Chemical Drugs | Supplementary Application | 2020-08-21 | 赛诺菲(中国)投资有限公司 | Sanofi (China) Investment Co Ltd | Filed | 2020-09-09 | view |